Archive for the 'Liver Disease' Category
‘Signifcant Step’ Towards Hep C Vaccine To Be Announced By University Of Alberta Researcher
A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery of a vaccine that will potentially help combat hepatitis C. Michael Houghton, who led the team that discovered the hepatitis C virus in 1989, announced his findings at the Canada Excellence Research Chairs Summit in Vancouver this afternoon…
Original post by Wife of a Diabetic
No commentsHepatitis Viruses Activated By Stress In Cells
People who have received a donor organ need lifelong immunosuppressant drugs to keep their immune system from attacking the foreign tissue. However, with a suppressed immune system, many infectious agents turn into a threat. Infections such as with human cytomegalovirus and a certain type of human polyomavirus frequently cause complications in transplant recipients…
Original post by Wife of a Diabetic
No commentsMuscle Mass Loss In Cirrhosis Patients Linked To Higher Death Rate
Medical researchers at the University of Alberta reviewed the medical records of more than 100 patients who had a liver scarring condition and discovered those who were losing muscle were more apt to die while waiting for a liver transplant…
Original post by Wife of a Diabetic
No commentsFirst European Clinical Practice Guidelines For Wilson’s Disease Published By EASL
The first European Clinical Practice Guidelines (CPGs) for the diagnosis and management of Wilson’s disease are published by the European Association for the Study of the Liver (EASL) on the EASL website*…
Original post by Wife of a Diabetic
No commentsFor Patients With Primary Biliary Cirrhosis, Rituximab A Possible Treatment Option
An open-label study of rituximab, a monoclonal antibody for human CD20, was shown to be safe in patients with primary biliary cirrhosis (PBC) who had an incomplete response to the standard ursodeoxycholic acid (UDCA) therapy, also known as Ursodiol…
Original post by Wife of a Diabetic
No commentsCoffee Consumption Reduces Fibrosis Risk In Those With Fatty Liver Disease
Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces the risk of advanced fibrosis in those with nonalcoholic fatty liver disease (NAFLD)…
Original post by Wife of a Diabetic
No commentsHepatitis Research May Benefit From Stem Cells
Hepatitis C is a viral disease that leads to inflammation and organ failure. However, researchers are puzzled as to why some individuals are very susceptible to the disease, while others are not. Researchers believe they could find out how genetic variations produce these different responses by investigating liver cells from different individuals in the lab…
Original post by Wife of a Diabetic
No commentsStem Cells Could Drive Hepatitis Research Forward
Hepatitis C, an infectious disease that can cause inflammation and organ failure, has different effects on different people. But no one is sure why some people are very susceptible to the infection, while others are resistant. Scientists believe that if they could study liver cells from different people in the lab, they could determine how genetic differences produce these varying responses…
Original post by Wife of a Diabetic
No commentsRecommendations For HPV And Hepatitis B Vaccinations Broadened By 2012 Adult Immunization Schedule
The CDC’s Advisory Committee on Immunization Practices (ACIP) now recommends routine HPV vaccination for males aged 11 to 12 years and catch-up vaccination for males aged 13 to 21. These are just two of the changes to the 2012 Recommended Adult Immunization Schedule published February 1 in Annals of Internal Medicine, the flagship journal of the American College of Physicians (ACP)…
Original post by Wife of a Diabetic
No commentsShedding Light On Nonalcoholic Fatty Liver Disease: Gene Mutation Linked To Accumulation Of Fat, Other Lipids In Liver
A team of scientists from the University of Utah and the University of California at San Francisco has discovered that the mutation of a gene encoding a ketone body transporter triggers accumulation of fat and other lipids in the livers of zebrafish. This discovery, published in the Feb…
Original post by Wife of a Diabetic
No comments